Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference38 articles.
1. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses. 2021;13(2):202.
2. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020. http://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 21 Aug 2022.
3. Heil EL, Kottilil S. The Goldilocks time for remdesivir—is any indication just right? N Engl J Med. 2022;386(4):385–7.
4. Pitts J, Li J, Perry JK, et al. Remdesivir and GS-441524 retain antiviral activity against delta, omicron, and other emergent SARS-CoV-2 variants. Antimicrob Agents Chemother. 2022;66(6): e0022222. https://doi.org/10.1128/aac.00222-22.
5. Gordon CJ, Tchesnokov EP, Woolner E, et al. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J Biol Chem. 2020;295(20):6785–97. https://doi.org/10.1074/jbc.RA120.013679.